Endocrine therapy stands as the cornerstone in HR+/HER2- advanced breast cancer. Targeting the ligand or the estrogen receptor results in cancer control, however the vast majority of the tumours will progress within the first year.
Searching for mechanisms to prevent or restore the endocrine sensitivity including cell survival, cell cycle and other cell signaling pathways (amongst the identification of primary or acquired actionable biomarkers) have shown to improve clinical long term outcomes. Defining and tailoring the best therapy sequencing is needed to achieve the longest and highest quality of living for our breast cancer patients.
Assistant Professor Jose Angel Garcia-Saenz is a Medical Oncologist and Head of the Breast Cancer Unit at the Medical Oncology Department, Hospital Clinico San Carlos in Madrid, Spain. He is also an Assistant Professor of Medicine at Complutense University of Madrid.
A Board Member and Coordinator of the Luminal Breast Cancer WG in the GEICAM Spanish Breast Cancer Group and author / co-author of over 150 papers published in peer-reviewed medical or scientific journals. Authorship in numerous chapters / books in medical oncology. Investigator in multiple breast cancer clinical trials and translational research studies.
The VCCC Alliance Research and Education (R&E Lead) Breast Cancer program has developed a learning environment where researchers and clinical care teams can share information to improve cancer outcomes.
The VCCC Alliance Breast Cancer Grand Round aims to provide a shared view of what is happening in the development of breast cancer care and is helping to stimulate discussion and collaborations among experienced and novice researchers and clinicians.
For further information on the program, please contact Jasper de Boer, VCCC Alliance Program Manager, Distributed Leadership [email protected]
This virtual event will be hosted via Zoom. Zoom is accessible on your computer, tablet or phone via the Zoom app. If you have any issues with this platform on your device, please visit the Zoom support site. Alternatively please contact your IT administrator.
